Anquan Shang

2.9k total citations · 1 hit paper
86 papers, 2.1k citations indexed

About

Anquan Shang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anquan Shang has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 34 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Anquan Shang's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (19 papers) and Extracellular vesicles in disease (16 papers). Anquan Shang is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (19 papers) and Extracellular vesicles in disease (16 papers). Anquan Shang collaborates with scholars based in China, Germany and United States. Anquan Shang's co-authors include Weiwei Wang, Chenzheng Gu, Junlu Wu, Zujun Sun, Wenying Lu, Bingjie Zeng, Ping Ji, Dong Li, Junjun Sun and Wenqiang Quan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Journal of Lipid Research.

In The Last Decade

Anquan Shang

85 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis

2020 342 citations Anquan Shang, Chenzheng Gu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anquan Shang China	25	1.4k	1.1k	334	332	176	86	2.1k
Shanshan Wu China	23	1.4k 1.0×	961 0.9×	206 0.6×	233 0.7×	164 0.9×	63	2.1k
Shanrong Liu China	24	1.5k 1.0×	976 0.9×	205 0.6×	414 1.2×	106 0.6×	56	2.1k
Minmin Shi China	29	1.1k 0.8×	733 0.7×	335 1.0×	407 1.2×	149 0.8×	81	2.2k
Sunan Shen China	17	875 0.6×	624 0.6×	361 1.1×	423 1.3×	157 0.9×	37	1.6k
Kazimierz Węglarczyk Poland	21	1.4k 0.9×	684 0.6×	517 1.5×	385 1.2×	130 0.7×	62	2.1k
Ping Ji China	21	1.1k 0.7×	651 0.6×	287 0.9×	253 0.8×	132 0.8×	67	1.6k
Pei Zhang China	23	1.2k 0.8×	636 0.6×	368 1.1×	356 1.1×	375 2.1×	109	2.1k
Jing Qian China	24	1.1k 0.7×	589 0.6×	239 0.7×	279 0.8×	196 1.1×	65	1.7k
Xi Zeng China	22	1.1k 0.8×	911 0.9×	226 0.7×	289 0.9×	146 0.8×	85	1.8k

Countries citing papers authored by Anquan Shang

Since Specialization

Citations

This map shows the geographic impact of Anquan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anquan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anquan Shang more than expected).

Fields of papers citing papers by Anquan Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anquan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anquan Shang. The network helps show where Anquan Shang may publish in the future.

Co-authorship network of co-authors of Anquan Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Anquan Shang. A scholar is included among the top collaborators of Anquan Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anquan Shang. Anquan Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xinyue, Anquan Shang, Haowei Chen, et al.. (2025). Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021. Drug Resistance Updates. 82. 101265–101265. 2 indexed citations

Zhao, Chenyang, et al.. (2024). Causal relationship between genetically predicted uterine leiomyoma and cancer risk: a two-sample Mendelian randomization. Frontiers in Endocrinology. 15. 1429165–1429165. 2 indexed citations

Xiu, Wang, et al.. (2024). The emerging role of the gut microbiota and its application in inflammatory bowel disease. Biomedicine & Pharmacotherapy. 179. 117302–117302. 36 indexed citations

Shang, Anquan, Yan Hong, Ze Xiang, et al.. (2024). Serum exosome-derived ALDH1A1 can greatly predict the prognosis of patients with hepatitis E virus-related acute liver failure. Hepatobiliary & pancreatic diseases international. 24(2). 170–176. 1 indexed citations

Shang, Anquan, et al.. (2024). Juvenile idiopathic arthritis and primary ovarian failure: a two-sample Mendelian randomization analysis in a mixed-gender cohort. Frontiers in Endocrinology. 15. 1340993–1340993. 1 indexed citations

Sun, Zujun, et al.. (2023). Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m6A-modified long non-coding RNAs in lung adenocarcinoma. Clinical Epigenetics. 15(1). 60–60. 3 indexed citations

Gu, Chenzheng, Anquan Shang, Wei Zhang, et al.. (2023). Identification of CD147-positive extracellular vesicles as novel non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer. Clinica Chimica Acta. 548. 117510–117510. 9 indexed citations

Gu, Chenzheng, Wenjing Chang, Junlu Wu, et al.. (2022). NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer. Journal of Oncology. 2022. 1–24. 11 indexed citations

Wang, Weiwei, et al.. (2022). Cervical Cancer Cells-Derived Extracellular Vesicles Containing microRNA-146a-5p Affect Actin Dynamics to Promote Cervical Cancer Metastasis by Activating the Hippo-YAP Signaling Pathway via WWC2. Journal of Oncology. 2022. 1–20. 13 indexed citations

10.

Gu, Chenzheng, Weiwei Wang, Wenhui Yan, et al.. (2022). Immune Infiltration and N(6)-Methyladenosine ncRNA Isoform Detection in Acute Lung Injury. Journal of Oncology. 2022. 1–19. 3 indexed citations

11.

Shang, Anquan, Zujun Sun, Wenjing Chang, et al.. (2022). Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma. Journal of Immunology Research. 2022. 1–9. 29 indexed citations

12.

Gu, Chenzheng, Junlu Wu, Yiwen Yao, et al.. (2022). Immune Infiltration of Ulcerative Colitis and Detection of the m6A Subtype. Journal of Immunology Research. 2022. 1–16. 12 indexed citations

13.

Zhang, Wei, Weiwei Wang, Junlu Wu, et al.. (2022). Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis. Frontiers in Oncology. 12. 942964–942964. 2 indexed citations

14.

Wang, Weiwei, et al.. (2022). Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer. Journal of Cancer. 13(2). 579–588. 32 indexed citations

15.

Gu, Chenzheng, et al.. (2021). MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clinical & Translational Oncology. 23(11). 2323–2334. 31 indexed citations

16.

Sun, Zujun, Junlu Wu, Jiale Tian, et al.. (2021). Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer. Frontiers in Oncology. 11. 725211–725211. 23 indexed citations

17.

Ji, Ping, Yibao Yang, Junlu Wu, et al.. (2019). Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling. Theranostics. 9(8). 2209–2223. 39 indexed citations

18.

Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2019). Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. Journal of Experimental & Clinical Cancer Research. 38(1). 272–272. 160 indexed citations

19.

Jia, Qi, et al.. (2017). Analysis on relationship between specific IgG antibodies of 14 food allergens and allergic skin diseases. Biomedical Research-tokyo. 28(22). 9982–9985.

20.

Shang, Anquan, Wenying Lu, Man Yang, et al.. (2017). miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway. Artificial Cells Nanomedicine and Biotechnology. 46(8). 1–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact